STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS

Emcure Pharmaceuticals Limited IPO Date, Price, Review and Details

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Emcure Pharmaceuticals Limited IPO

July 03, 2024 - July 05, 2024 Closed

Emcure Pharmaceuticals Limited IPO

Emcure Pharmaceuticals Limited IPO was engaged in are an Indian pharmaceutical company focused on creating, producing, and globally selling a wide variety of medicines in many important therapeutic areas. Driven by research and development (R&D), emcure pharmaceuticals ltd ipo offer a unique product range that includes oral medications, injectables, and biotherapeutics. This diverse portfolio allows them to serve markets in over 70 countries, with a strong presence in India, Europe, and Canada. They have 13 manufacturing plants in India. These facilities can produce a wide variety of pharmaceutical and biopharmaceutical products, such as oral tablets, liquid medicines, injectables (including liposomal and freeze-dried types), biotherapeutics, and complex active pharmaceutical ingredients (APIs) like chiral molecules, iron molecules, and cancer treatment drugs.

Company Promoters

  • Satish Ramanlal Mehta
  • Sunil Rajanikant Mehta
  • Namita Vikas Thapar
  • Samit Satish Mehta

Objects of this Issue:

  • Repayment and prepayment of all or a portion of certain outstanding borrowings availed by the company.
  • General corporate purposes

Financial Information of the Company:

 

Amount in Million (Rs.)

As on 31 Mar 2024

As on 31 Mar 2023

As on 31 Mar 2022

Total Assets

78,061.63

66,725.31

60,634.69

Total Liabilities

46,843.98

40,228.71

39,493.27

Net Profit

          527.58

561.85

702.56

Emcure Pharmaceuticals Limited IPO Schedule

1.      Bid or Offer Opens on: 03 July 2024
2.     Bid or Offer Closes on: 05 July 2024
3.     Finalization of BoA: 08 July 2024
4.     Initiation of Refunds: 09 July 2024
5.     Credit of share to Demat account: 09 July 2024
6.     Listing Date: 10 July 2024

Emcure Pharmaceuticals Limited IPO Lot Size

The market lot size of the EMCURE PHARMACEUTICALS LIMITED IPO is 1 share. Minimum and Maximum order quantity is as follows:

Application

Lots

Shares

Amount

Retail

Minimum

1

14

₹14,112

Maximum

14

196

₹197,568

S-HNI

Minimum

15

210

₹211,680

S-HNI

Maximum

70

980

₹987,840

B-HNI

Minimum

71

994

₹1,001,952

Company Contact Details:

Emcure Pharmaceuticals Limited IPO

Plot No. P-1 and P-2, IT-BT Park, Phase II,

M.I.D.C., Hinjawadi, Pune 411 057, Maharashtra, India.

Phone:   +91 20 3507 0033

Email:   investors@emcure.com

Website:  www.emcure.com

 

Emcure Pharmaceuticals Limited IPO Registrar Details:

Link Intime India Private Limited

C-101, 1st Floor, 247 ParkLal Bahadur Shastri Marg,

Vikhroli (West) Mumbai 400 083 Maharashtra

Phone: 91 810 811 4949

Email: emcure.ipo@linkintime.co.in

Website: www.linkintime.co.in


Frequently Asked Question

You will receive the allotted shares in your Demat account on July 08, 2024.
Post-issue shareholdings of Emcure Pharmaceuticals Limited IPO promoters are [.]%.
Face value of equity shares of Emcure Pharmaceuticals Limited IPO is ₹10.
Emcure Pharmaceuticals Limited IPO will be closed on 05 July 2024.
Price of 1 share of Emcure Pharmaceuticals Limited IPO is ₹960 to ₹1008.
Emcure Pharmaceuticals Limited IPO will get listed on July 10, 2024.
If you do not receive any shares, the funds blocked in your bank account for the IPO application will be unblocked or refunded.
Emcure Pharmaceuticals Limited IPO shares will get listed at NSE, BSE.
The meaning of "Emcure Pharmaceuticals Limited IPO GMP " is the Grey Market Premium (GMP) for the initial public offering (IPO) of Emcure Pharmaceuticals Limited IPO on the current day.
Investing in an IPO carries risks such as market volatility, company performance, and economic conditions. It is important to read the prospectus and understand the risks before investing.
Pre-issue shareholdings of Emcure Pharmaceuticals Limited IPO market promoters are 98.90%.
If you do not get the allotment of Emcure Pharmaceuticals Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Emcure Pharmaceuticals Limited IPO is going to open on 03 July 2024.
Market lot size of the Emcure Pharmaceuticals Limited IPO is 14 shares.
Link Intime India Private Limited is the registrar of Emcure Pharmaceuticals Limited IPO.
You can apply for an IPO from any place via the internet as it is an online process. You can apply for an IPO using 2 methods i.e., ASBA and UPI. ASBA facility is provided by your bank and UPI method is offered by your stockbroker. You can invest in Emcure Pharmaceuticals Limited IPO by using any one of these methods at your convenience.
Emcure Pharmaceuticals Limited IPO customer care number is 91 810811 4949
Price of 1 share of Emcure Pharmaceuticals Limited IPO is ₹960 to ₹1008.
Comments for Emcure Pharmaceuticals Limited IPO Date, Price, Review and Details

0 comments